Abstract
OBJECTIVES. 19mm-size aortic prostheses still raises concerns about long term effects of residual transprosthetic gradient, left ventricular mass, and patient's activity. We reviewed our experience with SJM 19 mm standard® and 17 mm supra-annular (SJM-HP® and Solin Bicarbon®) aortic valve prostheses for small aortic annulus. METHOD. Forty-six patients (2 men and 44 women, age 71 ± 8 years) operated on between April 1990 and August 2002 were enrolled in this study. The mean body surface area was 1.40±0.12 m2. Clinical late assessment was performed to evaluate the incidence of valve related complications, residual transprosthetic gradient, left ventricular mass index (LVMI), and NYHA functional class. Postoperative echocardiography was performed to evaluate hemodynamic performance of the prostheses. Follow up was 1 to 12.7 (mean 7.5) years. RESULTS. There was no hospital mortality (0%). Actuarial survival rates at 5 and 10 years were 97.4±2.5% and 97.4±2.5%. Actuarial freedom from valve-related events rates at 5 and 10 years were 89.4±5.9% and 89.4%. Late postoperative peak gradient was 24±12mmHg. LVMI was significantly reduced in late phase (preope vs. late, 189±49 vs. 138±57g/m2, p=0.004). NYHA functional class was significantly improved in late period. CONCLUSIONS. Although 19 mm size aortic valve prosthesis remains small transprosthetic pressure gradient, LVMI was significantly reduced and patients' activity was satisfactory maintained in late period.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.